ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Congress enacts Medicare reform, bill cuts oncology reimbursement.

November 28, 2003

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001

News Analysis: IOM Report A Case Study In Communications Disaster

February 5, 1999

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980

NCI Gets Out of the News Business

January 25, 2013